# Northernmost Medical Devices

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/northernmost-medical-devices

- Industry: Medical Devices & Equipment
- Headquarters: Edmonton, Canada
- Website: www.northernmost.ca
- Total disclosed funding: $1.9M
- Latest round: Seed (Apr 3, 2025)
- Investors on record: 5

## About

Northernmost Medical Devices, Inc. specializes in the design and development of innovative medical devices aimed at improving organ preservation, particularly for kidney transplantation.Northernmost Medical Devices, Inc. focuses on creating solutions for organ preservation. Founded in 2022 in Edmonton, Canada, the company has completed one deal as of April 3, 2025. It successfully raised CAD 2.7 million in a Seed funding round led by investors including Yaletown Partners, National Kidney Foundation, Leva Capital, ThresholdImpact, and Startup TNT. The founder has a history of involvement in the medical technology sector, contributing to the company's vision and growth strategy.Northernmost specializes in the development of advanced medical devices focused on organ preservation, specifically targeting the preservation and transport of donor kidneys for transplantation. Their flagship product, the NoMo™ Kidney Pump, is engineered to maintain optimal conditions for kidney perfusion throughout the transportation process, aiming to enhance the viability and effectiveness of transplants. This innovative device addresses critical challenges within the organ donation and transplantation sector, ultimately improving patient outcomes. The company markets its products primarily to hospitals, transplant centers, and medical facilities across North America, with efforts to expand into European and Asian markets.Northernmost's revenue generation relies on the sale of its proprietary medical devices, particularly the NoMo™ Kidney Pump, through direct partnerships with healthcare institutions and transplant organizations. The business structure is predominantly B2B, with transactions facilitated through contracts that outline pricing and delivery terms based on the specific needs of healthcare providers. Revenue is derived from the sale of devices as well as potential service agreements for maintenance and support, primarily from hospital systems and transplant centers, ensuring that the devices are used in critical care environments.In April 2025, Northernmost Medical Devices, Inc. raised CAD 2.7 million in Seed funding to accelerate product development and prepare for exhibitions at key industry events. The company is focusing on launching new products, with specific timelines for upcoming releases not disclosed. Furthermore, Northernmost aims to expand its market presence into Europe and Asia, targeting significant growth by 2026. The recent funding will be instrumental in driving these initiatives forward.

## Funding rounds

- Seed, Apr 3, 2025, $1.9M — Accelerate Fund, National Kidney Foundation, ThresholdImpact, Startup TNT, Leva Capital

## Investors

- Accelerate Fund — Seed
- National Kidney Foundation — Seed
- ThresholdImpact (https://capitalatlas.ai/funds/thresholdimpact) — Seed
- Startup TNT (https://capitalatlas.ai/funds/startup-tnt) — Seed
- Leva Capital (https://capitalatlas.ai/funds/leva-capital) — Seed